NCCR-Synapsy

The Synaptic Bases of Mental Diseases

NEWS & AWARDS

ALL SYNAPSY'S NEWS

JUMP TO A SPECIFIC MONTH
Protecting the intellectual abilities of people at risk for psychosis
22q11 deletion syndrome

Protecting the intellectual abilities of people at risk for psychosis

A Synapsy team based at UNIGE has found that a class of drugs can protect the development of intellectual abilities in people at risk of psychosis, if prescribed before adolescence....
Read More
Lactate reveals all about its antidepressant prowess
Mood disorders

Lactate reveals all about its antidepressant prowess

Neuroscientists at Synapsy have identified one of the mechanisms behind the antidepressant effect of lactate, a molecule produced by the body during exercise. Its key features – lactate, NADH and...
Read More
8 Replies
Overcoming long-term trauma can be facilitated
Developmental stress

Overcoming long-term trauma can be facilitated

Older traumatic experiences are harder to get over compared to recent ones, and Synapsy scientists based at EPFL have started to understand why – at the level of brain circuits...
Read More
Is schizophrenia the cost of a poor brain optimisation?
22q11 deletion syndrome

Is schizophrenia the cost of a poor brain optimisation?

Patients with 22q11.2 deletion syndrome have a high risk of developing schizophrenia. According to a recent study by neuroscientists from Synapsy, the Swiss National Research Centre of Competences in Research...
Read More
Why making the right choice is difficult when you’re stressed
Mood disorders

Why making the right choice is difficult when you’re stressed

Study by members of Synapsy, the Swiss National Centre of Competence in Research in psychiatric disorders, explains why we make poor decisions after stress even when motivated by the prospect...
Read More
Invitation for entries for the Research prize of the Swiss Brain League
Prize

Invitation for entries for the Research prize of the Swiss Brain League

Every two years, the Swiss Brain League awards a prize of CHF 20,000 to a Swiss research group in recognition of its outstanding scientific contribution in the field of neurological...
Read More
Has the ideal target for treating anxiety been discovered?
Mood disorders

Has the ideal target for treating anxiety been discovered?

Synapsy’s neuroscientists based at EPFL have identified a cell molecule that can regulate anxiety and prevent depression. Located at the crossroads of multiple cellular mechanisms, this molecule reconciles the great...
Read More
Poor wiring in the centre of the brain leads to psychosis
22q11 deletion syndrome

Poor wiring in the centre of the brain leads to psychosis

Psychosis is linked to abnormalities in brain development. A team from the Synapsy National Centre of Competences in Research has demonstrated that the regions of the brain involved in processing...
Read More
Best wishes for 2021
NEWS

Best wishes for 2021

The Management Team wishes You all the Best for the New Year!
Read More
From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders
Mood disorders Newsletter

From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders

We spoke with Charles Finsterwald, PhD, Chief Scientific Officer and co-founder of the start-up Gliapharm about his career path and his decision to switch from fundamental research to application.An interest...
Read More
Lactate, a prospect for the treatment of depression
Mood disorders Newsletter

Lactate, a prospect for the treatment of depression

According to WHO, more than 264 million people in the world suffer from depression, a disorder that has a major impact on all facets of the lives of those it...
Read More
Holography and cellular reprogramming in the quest for biomarkers
Mood disorders Newsletter

Holography and cellular reprogramming in the quest for biomarkers

Bipolar disorders affect some 2% of the population. Patients present a wide variety of clinical symptoms of which many can be especially handicapping. A new approach to find biomarkers, driven...
Read More
A career at the intersection of physics and psychiatry
Mood disorders Newsletter

A career at the intersection of physics and psychiatry

Pierre Marquet’s career path has been rather untypical. Combining qualifications in physics and psychiatry-psychotherapy, he is a clinical researcher “par excellence”, engaged for over 20 years in the development of...
Read More
From science to yoga — and back to science
Mood disorders Newsletter Women in Science

From science to yoga — and back to science

After initial studies in science, Zeynep Knight-Celen opts for a life practicing and teaching yoga. Ten years later her interest in the workings of the mind rekindles her scientific curiosity...
Read More
A psychologist in a clinical research team
Mood disorders Newsletter

A psychologist in a clinical research team

Ryan Murray’s work within Synapsy WP#5 focuses on measuring brain reactivity to and recovery from psychosocial stress within clinical patients and healthy controls. He talked to us about his role...
Read More
Genetics to stratify the WP#5 cohort
Mood disorders Newsletter

Genetics to stratify the WP#5 cohort

Giorgio Pistis is profiling polygenic scores to understand whether genetic risks associated with particular pathophysiological pathways are higher in specific sub-groups of patients of the mood disorder cohort. Synapsy met...
Read More
Editorial – by Camilla Bellone
Mood disorders Newsletter

Editorial – by Camilla Bellone

2020 has been a challenging year for the Synapsy community and for the whole society. The impact of the COVID-19 pandemic on health, economy and employment has been unprecedented worldwide....
Read More
Zoom Conference on Equal opportunity with Prof. Dr. Tom Welton
Equal opportunity

Zoom Conference on Equal opportunity with Prof. Dr. Tom Welton

A open conference organized by NCCR Molecular Systems with Prof. Dr. Tom Welton on the topic "Scientific Excellence and Equality – a Contradiction?" will take place November 4th, 13:30-15:10 on...
Read More
Johannes Gräff promoted to associate professor
NEWS Nomination

Johannes Gräff promoted to associate professor

Prof. Johannes Gräff, Synapsy principal investigator, has been promoted to Associate Professor of Life Sciences at the School of Life Sciences at EPFL. At its meeting of 23/24 September 2020...
Read More
Obsessive Compulsive Disorders: How to treat OCD?
Mood disorders

Obsessive Compulsive Disorders: How to treat OCD?

The fourth most common psychiatric illness, OCD affects between 2 and 3% of the population. Obsessive compulsive disorder, called OCD, is a psychological disorder. It is characterized by distressing obsessions...
Read More
1 2 3 14